Results 71 to 80 of about 4,466 (100)

[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Sun CY, Cai Z, Chen B, Chen LJ, Chen WM, Ding KY, Du J, Fu R, Fu CC, Gao D, Gao GX, He YJ, Hou J, Jiang M, Li F, Li J, Li J, Li ZY, Liao AJ, Liu J, Luo J, Luo JM, Ma YP, Mi JQ, Niu T, Peng HL, Song YP, Wang LQ, Zhan R, Zhang X, Hu Y.   +30 more
europepmc   +1 more source

A prognostic model for multiple myeloma based on lipid metabolism related genes. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Li Z, Zhao L, Shi F, Guo J, Zhou W.
europepmc   +1 more source

[Research progress in targeting GPRC5D for the treatment of multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
An JY, Pan MM, Ouyang HY, Mi JQ.
europepmc   +1 more source

[Chinese expert consensus on standard procedures for the outpatient management of patients with multiple myeloma (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Hematology Society of China Medicine Education Association.   +3 more
europepmc   +1 more source

Construction of a treatment response prediction model for multiple myeloma based on multi-omics and machine learning. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Zhou X, Gui R, Liu J, Gao M.
europepmc   +1 more source

[Progress in risk stratification and treatment of high-risk smoldering multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhou JQ, Hao M, An G.
europepmc   +1 more source

[Clinical characteristics and survival outcomes of patients with immunoglobulin A multiple myeloma in the bortezomib era: A single-center retrospective cohort study]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Gao F, Wang H, Zhou YL, Wang SX, Yu M, Li F.   +5 more
europepmc   +1 more source

[Expression of GPRC5D in newly diagnosed patients with multiple myeloma detected by flow cytometry and its prognostic value]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Jin CQ, Yan F, Ma A, Xu KL, Xia JY.
europepmc   +1 more source

[Renal response and prognosis of newly diagnosed patients with multiple myeloma with renal impairment applying VRD and autologous hematopoietic stem cell transplantation]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wu XY, Huang Y, Shen HM, You HY, Yan Z, Xie Y, Yao WQ, Yan S, Wang J, Zhai YY, Shi XL, Shang JJ, Jin S, Yan LZ, Wu DP, Fu CC.   +15 more
europepmc   +1 more source

[Chinese guidelines on response assessment and minimal residual disease monitoring in multiple myeloma (2024)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Multiple Myeloma Expert Committee of Chinese Society of Clinical Oncology (CSCO), Myeloma & Plasma Cell Disease Group, Hematology Oncology Committee of China Anti-Cancer Association (CACA).   +2 more
europepmc   +1 more source